Chronic low level arsenic exposure evokes inflammatory responses and DNA damage

International Journal of Hygiene and Environmental Health

Volumn 218, Issue 6, 2015, Pages 564-574

  Dutta, Kaustav ^a   Prasad, Priyanka ^a   Sinha, Dona ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

CD14; Groundwater; Inflammation; Low arsenic exposure; Oxidative DNA damage

Indexed keywords

8-OXO-7-HYDRODEOXYGUANOSINE; ARSENIC; AUTACOID; CD14 ANTIGEN; CYTOKINE; DEOXYGUANOSINE; GROUND WATER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANALYSIS; ARSENIC POISONING; BLOOD; CHEMISTRY; CROSS-SECTIONAL STUDY; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; FEMALE; GENETICS; HUMAN; INDIA; METABOLISM; MIDDLE AGED; NAIL; RURAL POPULATION; SPUTUM; YOUNG ADULT;

ADULT; ANTIGENS, CD14; ARSENIC; ARSENIC POISONING; CROSS-SECTIONAL STUDIES; CYTOKINES; DEOXYGUANOSINE; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; FEMALE; GROUNDWATER; HUMANS; INDIA; INFLAMMATION MEDIATORS; MIDDLE AGED; NAILS; NF-KAPPA B; RURAL POPULATION; SPUTUM; YOUNG ADULT;

EID: 84983135352     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2015.06.003     Document Type: Article

References (67)

1. Adams D.O., Hamilton T.A. The cell biology of macrophage activation. Annu. Rev. Immunol. 1984, 2:283-318. 10.1146/annurev.iy.02.040184.001435.
2. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511. 10.1016/j.jaci.2006.02.023.
3. Anas A., van der Poll T., de Vos A.F. Role of CD14 in lung inflammation and infection. Crit. Care. 2010, 14:209. 10.1186/cc9332.
4. Beutler B., Rietschel E.T. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 2003, 3:169-176.
5. Bureau of Indian Standards [BIS] Draft Indian Standard. Drinking Water Specification (Second Revision of IS 10500). Doc: FAD 25(2047) C 2009, Last date for comments: 24/12/2009. http://bis.org.in/sf/fad/FAD25(2047)C.pdf.
6. Calatayud M., Gimeno-Alcañiz J.V., Vélez D., Devesa V. Trivalent arsenic species induce changes in expression and levels of proinflammatory cytokines in intestinal epithelial cells. Toxicol. Lett. 2014, 224:40-46. 10.1007/s00204-014-1271-1.
7. Cataldo D., Munaut C., Noël A., Frankenne F., Bartsch P., Foidart J.M., Louis R. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int. Arch. Allergy Immunol. 2000, 123:259-267.
8. Chakraborti D., Das B., Rahman M.M., Chowdhury U.K., Biswas B., Goswami A.B., Nayak B., Pal A., Sengupta M.K., Ahamed S., Hossain A., Basu G., Roychowdhury T., Das D. Status of groundwater arsenic contamination in the state of West Bengal, India: a 20-year study report. Mol. Nutr. Food Res. 2009, 53:542-551. 10.1002/mnfr.200700517.
9. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867. 10.1038/nature01322.
10. Dacie J.V., Lewis S.M. Practical hematology 1975, Churchill Livingstone, London, UK. 5th ed.
11. Das D., Bindhani B., Mukherjee B., Saha H., Biswas P., Dutta K., Prasad P., Sinha D., Ray M.R. Chronic low-level arsenic exposure reduces lung function in male population without skin lesions. Int. J. Public Health 2014, 59:655-663. 10.1007/s00038-014-0567-5.
12. Das N., Paul S., Chatterjee D., Banerjee N., Majumder N.S., Sarma N., Sau T.J., Basu S., Banerjee S., Majumder P., Bandyopadhyay A.K., States J.C., Giri A.K. Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India. BMC Public Health 2012, 12:639. 10.1186/1471-2458-12-639.
13. Dey T.K., Banerjee P., Bakshi M., Kar A., Ghosh S. Groundwater arsenic contamination in West Bengal: current scenario, effects and probable ways of mitigation. Int. Lett. Nat. Sci. 2014, 8:45-58.
14. Ferrero-Miliani L., Nielsen O.H., Andersen P.S., Girardin S.E. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin. Exp. Immunol. 2007, 147:227-235. 10.1111/j.1365-2249.2006.03261.x.
15. Garai R., Chakraborti A.K., Dey S.B., Saha K.C. Chronic arsenic poisoning from tubewell water. J. Indian Med. Assoc. 1984, 82:34-35.
16. Ghosh P., Banerjee M., De S.C., Chowdhury R., Das J.K., Mukherjee A., Sarkar A.K., Mondal L., Baidya K., Sau T.J., Banerjee A., Basu A., Chaudhuri K., Ray K., Giri A.K. Comparison of health effects between individuals with and without skin lesions in the population exposed to arsenic through drinking water in West Bengal, India. J. Expo. Sci. Environ. Epidemiol. 2007, 17:215-223. 10.1038/sj.jes.7500510.
17. Guha Mazumder D.N. Chronic arsenic toxicity: clinical features, epidemiology, and treatment: experience in West Bengal. J. Environ. Sci. Health A: Toxic Hazard. Subst. Environ. Eng. 2003, 38:141-163.
18. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013.
19. Hensley K., Robinson K.A., Gabbita S.P., Salsman S., Floyd R.A. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 2000, 28:1456-1462.
20. Hinhumpatch P., Navasumrit P., Chaisatra K., Promvijit J., Mahidol C., Ruchirawat M. Oxidative DNA damage and repair in children exposed to low levels of arsenic in utero and during early childhood: application of salivary and urinary biomarkers. Toxicol. Appl. Pharmacol. 2013, 273:569-579. 10.1016/j.taap.2013.10.002.
21. Huber-Lang M., Barratt-Due A., Pischke S.E., Sandanger Ø., Nilsson P.H., Nunn M.A., Denk S., Gaus W., Espevik T., Mollnes T.E. Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice. J. Immunol. 2014, 192:5324-5331. 10.4049/jimmunol.1400341.
22. Hunt K.M., Srivastava R.K., Elmets C.A., Athar M. The mechanistic basis of arsenicosis: pathogenesis of skin cancer. Cancer Lett. 2014, 354:211-219. 10.1016/j.canlet.2014.08.016.
23. Jabaut J., Ckless K. Inflammation, immunity and redox signaling. Inflammation. Chronic Diseases and Cancer - Cell and Molecular Biology, Immunology and Clinical Bases. 2012, 145-160. InTech (Publisher), Rijeka, Croatia. M. Khatami (Ed.).
24. Kadl A., Sharma P.R., Chen W., Agrawal R., Meher A.K., Rudraiah S., Grubbs N., Sharma R., Leitinger N. Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2. Free Radic. Biol. Med. 2011, 51:1903-1909. 10.1016/j.freeradbiomed.2011.
25. Kallapura G., Pumford N.R., Hernandez-Velasco X., Hargis B.M., Tellez G. Mechanisms involved in lipopolysaccharide derived ROS and RNS oxidative stress and septic shock. J. Microbiol. Res. Rev. 2014, 2:6-11.
26. Kesari V.P., Kumar A., Khan P.K. Genotoxic potential of arsenic at its reference dose. Ecotoxicol. Environ. Saf. 2012, 80:126-131. 10.1016/j.ecoenv.2012.02.018.
27. Khaled Y.S., Ammori B.J., Elkord E. Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients. J. Immunol. Res. 2014, 2014:879897. 10.1155/2014/879897.
28. Lee I.T., Yang C.M. Role of NADPH oxidase/ROS in pro-inflammatory mediators-induced airway and pulmonary diseases. Biochem. Pharmacol. 2012, 84:581-590. 10.1016/j.bcp.2012.05.005.
29. Lee I.T., Yang C.M. Inflammatory signalling involved in airway and pulmonary diseases. Mediators Inflamm. 2013, 2013:791231. 10.1155/2013/791231.
30. Lee I.-T., Shih R., Lin C., Chen J., Yang C. Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells. Cell Commun. Signal. 2012, 10:33. 10.1186/1478-811X-10-33.
31. Lemarie A., Morzadec C., Bourdonnay E., Fardel O., Vernhet L. Human macrophages constitute targets for immunotoxic inorganic arsenic. J. Immunol. 2006, 177(September (5)):3019-3027. 10.4049/jimmunol.177.5.3019.
32. Li Q., Verma I.M. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2002, 2:725-734. 10.1038/nri910.
33. Liaudet L., Vassalli G., Pacher P. Role of peroxynitrite in the redox regulation of cell signal transduction pathways. Front. Biosci. (Landmark Ed.) 2009, 14:4809-4814.
34. Lin C.C., Tseng H.W., Hsieh H.L., Lee C.W., Wu C.Y., Chen C.Y., Yang C.M. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells. Toxicol. Appl. Pharmacol. 2008, 229:386-398. 10.1016/j.taap.2008.01.032.
35. Liu S., Sun Q., Wang F., Zhang L., Song Y., Xi S., Sun G. Arsenic induced overexpression of inflammatory cytokines based on the human urothelial cell model in vitro and urinary secretion of individuals chronically exposed to arsenic. Chem. Res. Toxicol. 2014, 27:1934-1942. 10.1021/tx5002783.
36. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
37. Martinez V.D., Vucic E.A., Becker-Santos D.D., Gil L., Lam W.L. Arsenic exposure and the induction of human cancers. J. Toxicol. 2011, 2011:431287. 10.1155/2011/431287.
38. Mautino G., Oliver N., Chanez P., Bousquet J., Capony F. Increased release of matrix metalloproreinase-9 in bronchoalveolar lavage fluid by alveolar macrophages of asthmatics. Am. J. Respir. Cell Mol. Biol. 1997, 17:583-591. 10.1165/ajrcmb.17.5.2562.
39. Miller G.E., Murphy M.L.M., Cashman R., Ma R., Ma J., Arevalo J.M.G., Kobor M.S., Cole S.W. Greater inflammatory activity and blunted glucocorticoid signaling in monocytes of chronically stressed caregivers. Brain Behav. Immun. 2014, 41:191-199.
40. Mokgobu M.I., Cholo M.C., Anderson R., Steel H.C., Motheo M.P., Hlatshwayo T.N., Tintinger G.R., Theron A.J. Oxidative induction of pro-inflammatory cytokine formation by human monocyte-derived macrophages following exposure to manganese in vitro. J. Immunotoxicol. 2015, 12:98-103. 10.3109/1547691X.2014.902877.
41. Mukherjee B., Bindhani B., Saha H., Sinha D., Ray M.R. Platelet hyperactivity, neurobehavioral symptoms and depression among Indian women chronically exposed to low level of arsenic. Neurotoxicology 2014, 45:159-167. 10.1016/j.neuro.2014.10.011.
42. Nathan C., Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat. Rev. Immunol. 2013, 13:349-361. 10.1038/nri3423.
43. Parajuli B., Sonobe Y., Kawanokuchi J., Doi Y., Noda M., Takeuchi H., Mizuno T., Suzumura A. GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia. J. Neuroinflamm. 2012, 9:268. 10.1186/1742-2094-9-268.
44. Pei Q., Ma N., Zhang J., Xu W., Li Y., Ma Z., Li Y., Tian F., Zhang W., Mu J., Li Y., Wang D., Liu H., Yang M., Ma C., Yun F. Oxidative DNA damage of peripheral blood polymorphonuclear leukocytes, selectively induced by chronicarsenic exposure, is associated with extent of arsenic-related skin lesions. Toxicol. Appl. Pharmacol. 2013, 266:143-149. 10.1016/j.taap.2012.10.031.
45. Rahman I., MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. J. Free Radic. Biol. Med. 2000, 28:1405-1420.
46. Rahman I., Mulier B., Gilmour P.S., Watchorn T., Donaldson K., Jeffery P.K., MacNee W. Oxidant-mediated lung epithelial cell tolerance: the role of intracellular glutathione and nuclear factor-kappaB. Biochem. Pharmacol. 2001, 62:787-794.
47. Ramsey K.A., Foong R.E., Sly P.D., Larcombe A.N., Zosky G.R. Early life arsenic exposure and acute and long-term responses to influenza A infection in mice. J. Environ. Health Perspect. 2013, 121:1187-1193. 10.1289/ehp.1306748.
48. Robinson J.M. Reactive oxygen species in phagocytic leukocytes. Histochem. Cell. Biol. 2008, 130:281-297. 10.1007/s00418-008-0461-4.
49. Samanta G., Sharma R., Roychowdhury T., Chakraborti D. Arsenic and other elements in hair, nails, and skin-scales of arsenic victims in West Bengal, India. J. Sci. Total Environ. 2004, 326:33-47.
50. Sellami H., Said-Sadier N., Znazen A., Gdoura R., Ojcius D.M., Hammami A. Chlamydia trachomatis infection increases the expression of inflammatory tumorigenic cytokines and chemokines as well as components of the Toll-like receptor and NF-κB pathways in human prostate epithelial cells. J. Mol. Cell Probes 2014, 28:147-154. 10.1016/j.mcp.2014.01.006.
51. Sies H. Biochemistry of oxidative stress. Angew Chem. Int. Edit. Engl. 1986, 25:1058-1078.
52. Shi X., Wei X., Koo I., Schmidt R.H., Yin X., Kim S.H., Vaughn A., McClain C.J., Arteel G.E., Zhang X., Watson W.H. Metabolomic analysis of the effects of chronic arsenic exposure in a mouse model of diet-induced fatty liver disease. J. Proteome Res. 2014, 13(2):547-554. 10.1021/pr400719u.
53. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
54. Sinha D., Mukherjee B., Bindhani B., Dutta K., Saha H., Prasad P., Ray M.R. Chronic low level arsenic exposure inflicts pulmonary and systemic inflammation. J. Cancer Sci. Ther. 2014, 6:62-69. 10.4172/1948-5956.1000250.
55. Slauch J.M. How does the oxidative burst of macrophages kill bacteria? Still an open question. Mol. Microbiol. 2011, 80:580-583. 10.1111/j.1365-2958.2011.07612.x.
56. States J.C., Srivastava S., Chen Y., Barchowsky A. Arsenic and cardiovascular disease. Toxicol. Sci. 2009, 107:312-323. 10.1093/toxsci/kfn236.
57. Surbatovic M., Veljovic M., Jevdjic J., Popovic N., Djordjevic D., Radakovic S. Immunoinflammatory response in critically ill patients: severe sepsis and/or trauma. Mediators Inflamm. 2013, 2013:362793. 10.1155/2013/362793.
58. Tseng C.H. The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol. Appl. Pharmacol. 2004, 197:67-83.
59. USEPA website: (accessed on 19.01.15). http://water.epa.gov/lawsregs/rulesregs/sdwa/arsenic/index.cfm.
60. WHO Fact sheet No. 372, 2012; No. 372; (accessed on 19.01.15). http://www.who.int/mediacentre/factsheets/fs372/en/.
61. Wu M.-M., Chiou H.-Y., Ho I.-C., Chen C.-J., Lee T.-C. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ. Health Perspect. 2003, 111:1429-1438.
62. Xie H., Huang S., Martin S., Wise J.P. Arsenic is cytotoxic and genotoxic to primary human lung cells. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2014, 760:33-41. 10.1016/j.mrgentox.2013.11.001.
63. Xu J., Fan G., Chen S., Wu Y., Xu X.M., Hsu C.Y. Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats. Brain Res. Mol. Brain Res. 1998, 59:135-142.
64. Xu Y., Zhao Y., Xu W., Luo F., Wang B., Li Y., Pang Y., Liu Q. Involvement of HIF-2α-mediated inflammation in arsenite-induced transformation of human bronchial epithelial cells. J. Toxicol. Appl. Pharm. 2013, 272:542-550. 10.1016/j.taap.2013.06.017.
65. Yang C.M., Hsieh H.L., Lee C.W. Intracellular signaling mechanisms underlying the expression of pro-inflammatory mediators in airway diseases. Chang Gung Med. J. 2005, 28:813-823.
66. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., Leenen P.J., Liu Y.J., MacPherson G., Randolph G.J., Scherberich J., Schmitz J., Shortman K., Sozzani S., Strobl H., Zembala M., Austyn J.M., Lutz M.B. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80. 10.1182/blood-2010-02-258558.
67. Zhao G., Yu R., Deng J., Zhao Q., Li Y., Joo M., Van Breemen R.B., Christman J.W., Xiao L. Pivotal role of reactive oxygen species in differential regulation of lipopolysaccharide-induced prostaglandins production in macrophages. Mol. Pharmacol. 2013, 83:167-178. 10.1124/mol.112.080762.